Ignite Creation Date:
2024-05-05 @ 4:59 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00365924
Status:
COMPLETED
Last Update Posted:
2009-03-23
First Post:
2006-08-16
Brief Title:
A Pilot Methodology Study To Evaluate Changes In Bone Quality Parameters Following Therapy With Forteo
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A Pilot Methodology Study To Evaluate Changes In Bone Quality Parameters Following Therapy With Recombinant Human Parathyroid Hormone PTH Forteo
Status:
COMPLETED
Status Verified Date:
2008-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This methodology trial will be conducted in patients with osteoporosis and will measure the changes in bone quality parameters micro- and macroarchitecture bone biomarkers and bone density following therapy with the approved drug Forteo
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None